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Objectives: The objective of this study was to assess the effects of a hyperproteic, hypercaloric oral
nutritional supplement with prebiotic ﬁber, vitamin D, and calcium, plus a standardized physical
intervention, in the functional status, strength, nutritional status, and quality of life of frail institution-
alized older adults.
Design: Multicentric prospective observational study under usual clinical practice conditions.
Setting: Four nursing homes from Burgos (2), Albacete, and Madrid, Spain.
Participants: Participants included 91 institutionalized older adults (age 70), able to walk 50 m, and
meeting at least 3 of the Fried frailty phenotype criteria.
Intervention: Daily intake of two 200-mL bottles of an oral nutritional supplement, each bottle containing
300 kcal, 20 g protein, 3 gﬁber, 500 IU vitaminD, and 480mg calcium, plus a standardized physical exercise
training consisting of ﬂexibility, balance, and strengthening exercises for arms and legs, 5 days per week.
Measurements: Short Physical Performance Battery (SPPB), Short-Form-Late-Life Function and Disability
Instrument (SF-LLFDI) function subscale, handgrip strength, EuroQoL-5 Dimensions visual analogic scale
(EQ5DVAS), weight, body mass index (BMI), and Short-Form Mini Nutritional Assessment (MNA-SF) at
baseline and 6 and 12 weeks.
Results: Forty-eight participants (52.7%) improved at least 1 point in the SPPB at week 6, and 44 (48.4%)
did so at week 12; 39 participants (42.9%) improved at least 2 points in the SF-LLFDI at week 6, and 46
(50.5%) at week 12. Participants improved their quality of life measured with the EQ5DVAS by 6% (95%
conﬁdence interval [CI] 3%e10%) at week 6, and by 5% (95% CI 0%e10%) at week 12. They also improved
their nutritional status (weight gain, BMI increase, and higher MNA-SF scores at 6- and 12-week follow-
up). This improvement was higher in participants with more frailty criteria, lower functional level, lower
vitamin D levels, and poorer nutritional status.
Conclusion: A 12-week intervention with oral nutritional supplementation plus physical exercise im-
proves function, nutritional status, and quality of life in frail institutionalized older adults.
 2015 AMDA e The Society for Post-Acute and Long-Term Care Medicine. This is an open access article
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P. Abizanda et al. / JAMDA 16 (2015) 439.e9e439.e16439.e10Physical frailty is a medical syndrome with multiple causes and
contributors that is characterized by diminished strength, endurance,
and reduced physiologic function that increases an individual’s
vulnerability for developing increased dependency and/or death.1,2
Frailty is a common syndrome in community-dwelling older adults,
with a pooled prevalence of 10.7% in more than 60,000 individuals.3
However, there are few studies that have analyzed these data in
institutionalized older adults, yielding a prevalence between 34.9%
and 68.8%.4e8 Frailty has been associated with health-related adverse
events like mortality,9 disability in basic activities of daily living
(BADLs), and mobility disability,10 hospitalization, institutionalization,
and falls in community-dwelling older adults,11 and recently the as-
sociation between frailty and incident mortality or disability in BADLs
in institutionalized older adults also has been demonstrated.12,13
Although frailty is a high prevalent condition associated with
adverse events in institutionalized older adults, few interventions have
focused on this target population. It is well known that exercise and
nutrition are effective interventions in frail community-dwelling older
adults.Oral nutritional supplementationhas agradeA recommendation
fromESPEN (European Society for Clinical Nutrition andMetabolism) to
improve or maintain nutritional status in frail older adults,14 and exer-
cise has been associated with many beneﬁts in this population,
including decrease/delay in frailty development, increase in physical
ﬁtness and strength, lower incidence of sarcopenia, lower incidence of
functional loss, better “brain health,” better repair of musculoskeletal
injuries, increase in quality of life and function, decrease in falls risk and
incidence, increase in bonemineral density, better gait andbalance, and
a 30% decrease in all-cause mortality and morbidity.15e18
In institutionalized older adults, physical exercise has demon-
strated to improve function as measured with the Barthel index, the
Rivermead Mobility Index, and the Timed Up and Go test, and it also
has been associated with a beneﬁcial effect on strength, ﬂexibility,
and balance, and possibly on mood. However, mean effects are small,
and may not be applicable to all residents.19e21 Regarding nutritional
supplementation, protein supplementation has been associated with
improvement in physical performance in frail older adults,22 and with
muscle mass increase when combined with resistance exercise.23
Moreover, low vitamin D levels have been associated with increased
mortality in nursing home residents,24,25 and supplementation in this
population has been associated with a reduced rate of falls.26
Despite the evidence presented, there are few studies with both
physical exercise plus nutrition intervention in this population,27,28
and no speciﬁc studies to analyze if a combined intervention of
physical exercise plus nutritional supplementation enriched with
vitamin D, calcium, and ﬁber, in frail institutionalized older adults,
would improve functional and nutritional status, and quality of life.
This was the reason to design the ACTIVNES study.
Methods
Objective
The main objective was to assess the effects of a hyperproteic,
hypercaloric (HP/HC) oral nutritional supplement (ONS) with prebi-
otic ﬁber, vitamin D, and calcium, plus a standardized physical
intervention, in the functional status, strength, nutritional status, and
quality of life of frail institutionalized older adults in Spain, under
usual clinical practice conditions.
Design
This was a multicentric prospective observational study under
usual clinical practice conditions in 4 institutions from Spain (n ¼ 91).
The 4 institutionswere “Residencia Jardín” and “Residencia demayoresFuentesBlancas,”both in Burgos, “Residencia ORPEAGroup SanBlas” in
Madrid, and “Residencia de Mayores Núñez de Balboa” in Albacete.
Population
Inclusion criteria were patients 70 years or older, able to walk
50 m, and living in one of the institutions previously described. Pa-
tients had to meet at least 3 of the Fried frailty phenotype criteria as
originally proposed by the author with the same cut points (unin-
tentional weight loss over 4.5 kg or 5% in the past year, exhaustion in
the past week, slow walking speed, low physical activity, and low
handgrip strength). Participants had to be able to accomplish a daily
physical exercise plan, and they had to be already taking for less than
3 weeks or starting to take an HP/HC nutritional formula with pre-
biotic ﬁber, vitamin D, and calcium. Written informed consent was
necessary before enrollment in the study.
Intervention
ONS (Resource Senior Activ; Nestlé Health Science-NHS, Barcelo-
na, Spain) consisted of daily intake of 2 bottles of 200 mL. Each bottle
contains 300 kcal, 20 g protein, 24.2 g carbohydrate, 13 g fat (poly-
unsaturated fatty acids 18.5%; u6/u3 ¼ 2.8:1), 3 g ﬁber (30% inulin,
70% fructooligosaccharides), 500 IU vitamin D, and 480 mg calcium.
Intake was calculated to increase 30% of daily kilocalories.
Standardized physical exercise training (ActiPlan; Nestlé Health
Science-NHS) is presented in Figure 1. It was conducted 5 days per
week and was supervised by physiotherapists. After evaluation of the
ability to perform physical exercise, ﬂexibility, balance, and
strengthening exercises for arms and legs were prescribed. There was
a safety assessment plan, and a daily adherence evaluation plan.
Every 2 weeks there was an evaluation of progression, measuring
volume, intensity, and number of repetitions.
Outcome Variables
All outcome variables were measured at baseline and at weeks 6
and 12, except blood sample parameters that were recorded only at
baseline and at 12-week follow-up.
The Short Physical Performance Battery (SPPB) is a questionnaire
of 5 items and 3 dimensions: balance, walking speed, and time to
stand up from a chair 5 times. Score ranges from 0 (poor perfor-
mance) to 12 (best performance).29 Participants were classiﬁed as
poor function (0e3 points), intermediate function (4e7 points), and
high function (8e12 points). We considered the minimal clinical
important difference (MCID) an increase of 1 point between baseline
and follow-up data.30
The Spanish version of the Short-Form-Late-Life Function and
Disability Instrument (SF-LLFDI), function subscale, is a 15-item
questionnaire to assess functional limitations in older adults. Score
ranges from 15 (high functional limitation) to 75 (absence of func-
tional limitation).31 Although there are no data regarding the MCID
for this test,32 we considered an increase of 2 points (moderate
improvement at least in 2 functions or great improvement in 1
function) as the probable MCID.
Handgrip strength was assessed with a JAMAR dynamometer
(Sammons Preston Rolyan, Bolingbrook, IL) following the recom-
mendation of the American Society of Hand Therapists.
The EuroQoL-5 Dimensions (EQ-5D) is a generic health index of
quality of life, that comprises a 5-part questionnaire and a visual
analogic self-rating scale (VAS).33 We calculated the EQ-5D health
index by applying a weighting system previously validated, scoring
from 0.59 (lower quality of life, worse than dead) to 1 (full health),
and the VAS (0 to 100%).
Fig. 1. ActiPlan in English.
P. Abizanda et al. / JAMDA 16 (2015) 439.e9e439.e16 439.e11Nutritional parameters: Weight (kg), height (cm), and body mass
index (BMI; kg/m2) were recorded. The Short-Form Mini Nutritional
Assessment (MNA-SF) is a 6-item scale that assesses nutritional risk,
ranging from 0 (poorer nutritional state) to 14 (better nutritional
state). Malnutrition was considered with scores 0 to 7, nutritional risk
with scores 8 to 11 and good nutritional state with scores 12 to 14.
Bioimpedance analysis (BIA) also was conducted at 6 and 12 weeks of
follow-up, determining fat mass (kg and %) and fat-free mass (FFM;
kg). A blood sample was analyzed measuring total proteins (g/dL),
albumin (g/dL), transferrin (mg/dL), cholesterol (mg/dL), vitamin D
(ng/mL), and hemoglobin (g/dL).
Control Variables
At baseline, the following control variables were recorded: Age,
sex, chronic diseases, and the Folstein Mini-Mental State Examination
(MMSE).
Adherence to Intervention and Adverse Events
Daily adherence to physical exercise and ONS was assessed.
Excellent adherence was considered when higher than 80%
of the intervention planned, and good adherence when higher
than 60%.Nausea, vomiting, diarrhea, ﬂatulence, constipation, and abdom-
inal pain were monitored at 6- and 12-week follow-up. Serious
adverse events during the study follow-up were death in 6 cases, and
hospitalization in 3 cases, none of them related to the study inter-
vention. Intervention had to be prematurely stopped in 5 cases. In 2
cases there was ONS intolerance, in 2 others there was physical ex-
ercise intolerance, and in 1 case there was intolerance to both
interventions.
Ethics
The study was approved by the Ethics Committee of the Hospital
Clínic i Provincial de Barcelona, March 8, 2012. Our investigation
complies with the standards of the Helsinki declaration concerning
investigation with human subjects. All participants signed an
informed consent form before inclusion in the study.
Statistics
A descriptive analysis of the subjects’ characteristics was per-
formed using proportions and measures of central tendency and
dispersion according to the nature of the variables. Subsequently, a
bivariate analysis was performed using the paired Student t test to
determine differences in functional, nutritional, quality of life, BIA,
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follow-up. The percentage of participants improving the MCID of
functional tests was calculated. Pearson c2 tests (when frequency of
cells was <5, the Fisher exact test was used) were used for deter-
mining the association between control variables and the presence of
MCID of functional variables, at the 6- and 12-week follow-up. When
control variables had 3 or more categories, linear per linear associa-
tion also was analyzed to determine tendencies.
Last, we underwent a multivariant analysis with logistic regres-
sion models to describe the variables independently associated with
MCID in SPPB. In the model we included age, sex, presence of 5 Fried
frailty criteria, low vitamin D values, and BMI. This model classiﬁed
correctly 80.6% of the study population.
All data were stored and analyzed using the SPSS 17.0 software
program (IBM SPSS Statistics, IBM Corporation, Chicago, IL).
Results
The study ﬂow chart is presented in Figure 2. A total of 91 resi-
dents participated in the study. At week 6, 80 participants remained
in the study and 11 abandoned (12.1%), and at week 12, 69 completed
the study and 22 had an early termination. The causes of early
termination were death in 6 cases, patient desire in 4 cases, hospi-
talization in 3 cases, intervention stop in 5 cases (2 ONS stop, 2
physical exercise stop, and 1 both), and lost to follow-up in 4 cases.
The baseline characteristics of those who abandoned the study (age,
sex, nutritional status, functional status, chronic diseases, cognitive
status, blood parameters, BIA, and quality of life) did not differ
signiﬁcantly from those who completed it.
Baseline characteristics of the complete sample, both in men and
women, and of participants completing the study are presented in
Table 1. The prevalence of at least 1 chronic disease was 98.9%, the
more frequent pathologies were the following: cardiovascular
(72.5%), neurologic/psychiatric (65.9%), musculoskeletal (60.4%),
gastrointestinal/hepatic (45.1%), endocrine/metabolic (41.8%), geni-
tourinary (29.7%), infectious (14.3), respiratory (14.3%), cancer (8.8%),
and others (34.1%).
Adherence to ONS was higher than 80% in 62.6% of participants,
between 60% and 80% in 20.9% of participants, between 40% and 60%
in 8.8% of participants, between 20% and 40% in 1.1% of participants,
and in 6.6% of participants data were not available. Adherence to
physical exercise was higher than 80% in 93.4% of participants,Fig. 2. Study ﬂbetween 60% and 80% in 4.4% of participants, between 40% and 60% in
1.1% of participants, and in 1.1% of participants data were not avail-
able. Regarding exercise intervention, 70.2% of patients followed the
plan, and in 29.8% it was necessary to replace some exercises, most
frequently squatting, walking in line, and standing on one leg.
The number of participants with secondary effects of ONS at week
6 and between weeks 6 and 12 were, respectively, nausea 5 (5.5%)
and 2 (2.2%), vomiting 3 (3.3%) and 0 (0%), diarrhea 7 (7.7%) and 3
(3.3%), ﬂatulence 13 (14.3%) and 5 (5.5%), constipation 8 (8.8%) and 3
(3.3%), and abdominal pain 7 (7.7%) and 1 (1.1%). Only 1 case of
diarrhea at week 6, another one between weeks 6 and 12, and 1 case
of ﬂatulence at week 6 were considered of severe intensity.
Table 2 presents the evolution of functional, nutritional, quality of
life, BIA, and main blood sample parameters between baseline and 6
and 12 weeks of follow-up. Mean improvement in SPPB at week 6
was 0.8 points, and in SF-LLFDI 3.1 points. Although there was no
signiﬁcant improvement in function at week 12, mean values were
higher at that point than at baseline. Participants improved their
quality of life at week 6, measured with the EQ-5D index and EQ-5D
VAS, and at 12 weeks measured with the EQ-5D VAS. Moreover,
participants improved their nutritional status; weight gain, BMI in-
crease, and higher MNA-SF scores were recorded at the 6- and 12-
week follow-up. Regarding blood parameters, only vitamin D and
transferring increased at week 12.
At week 6, 48 participants (52.7%) improved SPPB at least 1 point
(MCID), and 44 (48.4%) did so at week 12. Regarding SF-LLFDI, 39
participants (42.9%) improved at least 2 points at week 6, and 46
(50.5%) at week 12.
Table 3 presents the association between the main control vari-
ables and the presence of MCID in functional tests at the 6- and 12-
week follow-up. Participants had greater probability of improving
functional status measured with the SPPB and SF-LLFDI when they
presented with lower baseline SPPB scores, lower baseline BMI, lower
vitamin D levels, and more baseline frailty criteria.
Table 4 presents multivariate analysis between control variables
and functional improvement measured with the SPPB. The presence
of 5 Fried frailty criteria was independently associated with better
functional outcomes, and lower vitamin D levels with improvement
in SPPB at week 6.
Participants with low baseline vitamin D levels presented signif-
icant improvement in function at 6 weeks, but there was no increase
in FFM between baseline and 12-week follow-up in the completeow chart.
Table 2
Evolution of Outcome Variables at 6- and 12-Week Follow-up
Baseline to 6-wk
Means (Mean Difference; 95% CI)
Baseline to 12-wk
Means (Mean Difference; 95% CI)
Function
SPPB 6.8e7.6 (0.8; 0.5e1.1)z 6.7e6.8 (0.1; 0.7e1.0)
SF-LLFDI 46.5e49.6 (3.1; 1.8e4.4)z 46.8e47.6 (0.8; 2.3e3.8)
Grip strength, kg 15.5e16.0 (0.5; 0.5e1.5) 16.5e17.1 (0.6; 0.5e1.6)
EQ-5D
EQ-5D index 0.58e0.62 (0.04; 0.01e0.07)* 0.58e0.59 (0.00; 0.06e0.06)
EQ-5D VAS 60e66 (6; 3e10)y 59e64 (5; 0e10)*
Nutrition
Weight, kg 59.9e60.7 (0.8; 0.3e1.2)y 59.9e61.6 (1.7; 0.9e2.5)z
BMI, kg/m2 26.4e26.8 (0.4; 0.2e0.6)z 26.5e27.3 (0.8; 0.4e1.2)z
MNA-SF 10.1e11.5 (1.4; 0.9e1.9)z 10.3e11.1 (0.8; 0.1e1.5)*
BIA
FFM, kg 42.2e42.5 (0.3; 0.6e1.2) 41.4e41.3 (0.1; 1.1e1.0)
Fat mass, kg 18.7e20.3 (1.6; 0.5e3.6) 17.6e19.1 (1.5; 0.5e2.4)y
Fat mass, % 29.8e30.5 (0.7; 0.5e1.9) 29.1e31.0 (1.9; 0.5e3.3)y
Blood parameters
Albumin, g/dL d 3.7e3.8 (0.1; 0.1e0.2)
Total proteins, g/dL d 6.7e6.6 (0.1; 0.4e0.2)
Vitamin D, ng/mL d 17.4e25.3 (7.9; 5.0e10.8)z
Parathormone, pg/mL d 53.5e53.8 (0.3; 6.5e7.0)
Hemoglobin, g/dL d 13.0e13.4 (0.4; 0.0e0.7)
C-reactive protein, mg/dL d 3.6e4.3 (0.7; 0.6e2.2)
Transferrin, mg/dL d 235e248 (13; 0.8e25.0)*
Total cholesterol, mg/dL d 177e178 (1; 7e8)
Note: Dashes represent non available data. Blood parameters were not determined at 6-week follow-up.
*P < .05.
yP < .01.
zP < .001.
Table 1
Baseline Characteristics of the Sample
Variable All Sample, n ¼ 91 Male, n ¼ 27 Female, n ¼ 64 Completing Study, n ¼ 69
Age, y 85.6 (5.6) 83.9 (5.7) 86.3 (5.4) 85.8 (5.5)
Body weight, kg 59.9 (12.3) 64.8 (9.7)* 57.8 (12.7)* 59.7 (11.8)
Usual weight, kg 62.2 (11.7) 67.7 (9.4)y 59.8 (11.9)y 62.1 (11.7)
Fat mass, % 28.9 (9.1) 24.9 (7.9)y 30.6 (9.1)y 29.6 (9.6)
Fat mass, kg 17.8 (8.1) 16.5 (7.2)z 18.3 (8.5)z 18.2 (8.5)
FFM, kg 41.9 (7.6) 48.0 (6.3) 39.3 (6.5) 41.3 (7.2)
MNA-SF mean 10.2 (2.4) 10.3 (2.6) 10.2 (2.4) 10.3 (2.3)
12e14 37 (40.7) 9 (33.3) 28 (43.8) 27 (39.1)
8e11 39 (42.9) 14 (51.9) 25 (39.1) 32 (46.4)
0e7 14 (15.4) 4 (14.8) 10 (15.6) 9 (13.0)
BMI mean, kg/m2 26.4 (5.1) 25.8 (3.9) 26.6 (5.5) 26.5 (4.8)
<18.5 2 (2.2) 0 (0.0) 2 (3.1) 1 (1.4)
18.5e24.9 39 (42.9) 12 (44.4) 27 (42.2) 28 (40.6)
25e29.9 30 (33.0) 11 (40.7) 19 (29.7) 26 (37.7)
30 20 (22.0) 4 (14.8) 16 (25.0) 14 (20.3)
<23 27 (29.7) 7 (25.9) 20 (31.3) 18 (26.1)
23 64 (70.3) 20 (74.1) 44 (68.8) 51 (73.9)
Frailty criteria
Weight loss 52 (57.1) 19 (70.4) 33 (51.6) 40 (58.0)
Exhaustion 84 (92.3) 25 (92.6) 59 (92.2) 64 (92.8)
Slowness 88 (96.7) 26 (96.3) 62 (96.9) 67 (97.1)
YPhysical activity 82 (90.1) 24 (88.9) 58 (90.6) 64 (92.8)
Weakness 69 (75.8) 18 (66.7) 51 (79.7) 55 (79.7)
3 Criteria 25 (27.5) 9 (33.3) 16 (25.0) 16 (23.2)
4 Criteria 30 (33.0) 5 (18.5) 25 (39.1) 23 (33.3)
5 Criteria 36 (39.6) 13 (48.1) 23 (35.9) 30 (43.5)
Grip strength, kg 16.2 (7.4) 20.5 (7.9)z 14.3 (6.3)z 16.0 (6.8)
SPPB 6.8 (2.8) 6.8 (2.7) 6.8 (2.9) 6.7 (2.9)
SF-LLFDI 46.9 (12.8) 47.5 (13.6) 46.6 (12.6) 46.3 (13.1)
EQ-5D index 0.58 (0.22) 0.61 (0.23) 0.57 (0.21) 0.59 (0.23)
EQ-5D VAS 59.6 (21.0) 58.4 (24.1) 60.1 (19.7) 59.1 (22.0)
MMSE 21.6 (6.3) 24.3 (5.3)* 20.6 (6.4)* 21.8 (5.9)
Note: All data are mean (standard deviation) or number of participants (percentage).
*P < .05.
yP < .01.
zP < .001.
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Table 3
Association Between Control Variables and Minimal Clinical Signiﬁcant Improvement in Functional Outcomes at 6- and 12-Week Follow-up
SPPB 6-wk, Improvement
1 Point, n (%)
SPPB 12-wk, Improvement
1 Point, n (%)
SF-LLFDI 6-wk, Improvement
2 Points, n (%)
SF-LLFDI 12-wk, Improvement
2 Points, n (%)
Baseline SPPB
0e3 6 (66.7)y 9 (100) 7 (87.5)z 8 (88.9)*
4e7 28 (77.8)y 24 (75.0) 19 (59.4)z 22 (62.9)*
8e12 14 (40.0)y 11 (39.3) 13 (44.8)z 16 (45.7)*
Baseline BMI, kg/m2
<18.5 1 (100)* 1 (100)* 1 (100)z 1 (100)
18.5e24.9 26 (76.5)* 22 (78.6)* 18 (66.7)z 21 (61.8)
25e29.9 14 (51.9)* 16 (61.5)* 16 (59.3)z 16 (59.3)
30 7 (38.9)* 5 (35.7)* 4 (28.6)z 8 (47.1)
Frailty criteria
3 9 (42.9)y 10 (62.5) 6 (35.3)* 7 (33.3)*
4 12 (48.0)y 11 (47.8) 11 (50.0)* 14 (58.3)*
5 27 (79.4)y 23 (76.7) 22 (73.3)* 25 (73.5)*
Vitamin D
<20 ng/mL 39 (67.2)* 12 (63.2) 30 (60.0) 34 (59.6)
20 ng/mL 9 (40.9)* 32 (64.0) 9 (47.4) 12 (54.5)
*P < .05.
yP < .01.
zLinear per linear association P < .05.
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20 ng/mL had a decrease in FFM of 0.62 kg, whereas those with
higher vitamin D levels had an increase of 1.23 kg (difference 1.85,
95% conﬁdence interval [CI] 0.31e4.19; P ¼ .09) at week 12.
Discussion
The main result of our study is that an intervention with a HP/HC
ONS with vitamin D and calcium plus physical exercise, in frail
institutionalized older adults, improved functional status at 6 weeks,
nutritional status at weeks 6 and 12, and quality of life at weeks 6 and
12. To our knowledge, this is the ﬁrst intervention study conducted
speciﬁcally in frail institutionalized older adults with a mixed nutri-
tional and exercise intervention.
Interestingly, our study also identiﬁed older adults with higher
probability of improving their functional status. Those with lower
BMI, lower previous physical function, higher number of frailty
criteria, and lower vitamin D levels had an independent association
with functional improvement. This is in agreement with previous
studies demonstrating the beneﬁts of low-to medium-intensity ex-
ercise and nutrition interventions in this targeted population.15,34
Frailty is a common condition in institutions, as has been
demonstrated in recent studies,4e8 and has been independently
associated with mortality and disability in this population.13 How-
ever, it is still not known if valid interventions for frail community-
dwelling older adults could be valid for nursing home populations,
due to their special characteristics with high rates of disability,
multimorbidity, and geriatric syndromes. Our study adds to previous
research that it is possible to identify and recruit frail older people for
clinical studies, and that treating frailty in older people is a realisticTable 4
Models to Determine Independent Association Between Control Variables and Functiona
SPPB 6-wk, Improvement
1 Point, OR (95% CI)
SPPB 12-wk, Improve
1 Point, OR (95% CI)
Age, y 0.99 (0.90e1.09) 0.97 (0.87e1.07)
Female sex 1.58 (0.51e4.92) 1.57 (0.50e4.93)
5 Frailty criteria 3.94 (1.28e12.13)* 2.18 (0.71e6.72)
BMI, kg/m2, <25 2.55 (0.86e7.51) 2.97 (0.91e9.68)
Vitamin D, ng/mL, <20 3.32 (1.05e10.52)* 0.88 (0.27e2.88)
OR, odds ratio.
*P < .05.
yP < .01.therapeutic goal. The good results observed, even though residents
were rather very frail individuals, suggest the need to reinforce
nutrition and exercise interventions in prefrail and community-
dwelling frail older adults, rather than wait for patients to be insti-
tutionalized due to higher dependency.
It is of interest that only 15.4% of our sample had malnutrition
using the MNA-SF, 42.9% were at risk of malnutrition, and 40.7% were
well-nourished, and that all of them were treated with ONS. The
rationale for this intervention was based on ESPEN guidelines,14 and
we need to state that we were not only treating malnutrition, but
treating frailty. Even though ESPEN recommendations regarding
frailty and ONS is correct to maintain or improve nutritional status,
the results of our study suggest the possibility of extending the
recommendation of combined ONS and physical exercise to improve
frailty standards of care beyond current usual clinical practice. We
could not analyze the individual effect of nutritional supplementation
and exercise on the outcome variables, because our intervention was
designed as a global combined approach. Recent ongoing studies in
community-dwelling frail older adults also are incorporating this
approach.35
Physical frailty is a state of reduced physiological reserve associ-
ated with an increased vulnerability leading to disability. Poor
nutritional status, low protein intake, low physical activity, and low
vitamin D levels have been identiﬁed among other pathophysiologic
factors leading to frailty,36 and multidomain interventions have been
proposed for its treatment, including nutrition and physical exer-
cise.37 Because physical inactivity and dietary inadequacies are among
the main contributors,27 it seemed appropriate to focus the actual
investigation primarily on these risk factors. Our positive results could
have been achieved through an increase of vitamin D levels, anl Outcomes at 6- and 12-Week Follow-up
ment SF-LLFDI 6-wk, Improvement
2 Points, OR (95% CI)
SF-LLFDI 12-wk, Improvement
2 Points, OR (95% CI)
1.03 (0.94e1.14) 1.14 (1.03e1.26)y
0.69 (0.22e2.14) 0.71 (0.23e2.14)
3.17 (1.06e9.48)* 3.22 (1.10e9.43)*
1.37 (0.45e4.22) 0.86 (0.30e2.48)
1.59 (0.51e4.99) 0.96 (0.32e2.87)
P. Abizanda et al. / JAMDA 16 (2015) 439.e9e439.e16 439.e15increase in muscle synthesis, an improvement of strength and bal-
ance, an increase of other nutritional elements, or a combination of all
of them. We could only demonstrate an increase of vitamin D levels,
an increase in grip strength, and an increase in nutritional status,
although it is not possible to exclude the participation of the other
factors, or the relative individual importance of all of them.
Regarding blood sample parameters, we could only demonstrate a
signiﬁcant increase in vitamin D and transferring between baseline
and 12-week follow-up, and a nonsigniﬁcant increase in hemoglobin.
Participants were mostly deﬁcient in vitamin D levels, and inter-
vention showed to be effective at increasing their levels. However,
there was no increase in total proteins, albumin, and cholesterol.
Possibly, participants did not need to compensate these parameters
because at baseline they were in normal levels, as shown in Table 2.
Function was improved without an increase in FFM, but with an
increase in vitamin D levels. Vitamin D status is positively associated
with muscle strength and physical performance and inversely asso-
ciated with risk of falling, and clinical trials of vitamin D supple-
mentation in older adults with low vitamin D status mostly report
improvements in muscle performance and reductions in falls. The
underlying mechanisms are probably both indirect via calcium and
phosphate and direct via activation of the vitamin D receptor on
muscle. This activation at the genomic level regulates transcription of
genes involved in calcium handling and muscle cell differentiation
and proliferation, thus increasing muscle ﬁber size and number.
Moreover, vitamin D has shown to improve muscle function and
contraction.38,39 In our study, although participants with low vitamin
D values presented a better improvement in function, only partici-
pants with vitamin D values over 20 ng/mL showed FFM increase.
High-range vitamin D increase could be necessary for increasing ﬁber
size and number, while increases in the lower range could improve
muscle function.
The rationale for using ONS instead of properly introducing the
micronutrients (proteins, calcium, vitamin D, and ﬁber) separately is
multifactorial. First, it is easier for frail older adults to have 1 single
product intake than using different products for each compound.
Second, for study precision, ONS allows the exact quantiﬁcation of all
micronutrient intake in a frail population with difﬁculties in com-
plementing a normal oral diet. Third, it has been recently described
that managing several patient populations suffering from or at risk of
disease-related malnutrition in different health care settings with
ONS seems to be an efﬁcient intervention from a health economic
perspective, in most cases even leading to cost savings.40
Probably the most important limitation of our study is the absence
of a control group. However, we think that there is enough evidence
to consider bad practice an intervention on frail older adults not
including physical exercise and nutrition actions. It could be argued
that a dietary intervention without ONS could have been appropriate.
However, our intervention not only allowed the quantiﬁcation of
nutritional intake including kilocalories, proteins, ﬁber, calcium, and
vitamin D, but also allowed the possibility of monitoring adherence.
This is important in a frail population usually characterized by low
nutritional intake.41 In keeping with studies of this type, it was not
possible to blind participants and treating clinicians to the inter-
vention, making feasible a participation bias. However, database
treatment and statistical analysis were blinded, and the study Pro-
motor did not take part in any of these study processes. We also
decided that our main outcome function variables had to meet 2
characteristics: First, we needed a performance-based measure that
could reduce observer bias, and second, we needed a scale with low
ceiling and ﬂoor effects. These were the reasons for choosing SPPB
and SF-LLFDI. Although our study was multicentric, more centers
from more countries, from different types of institutions and with a
larger sample, could be of interest for conﬁrming our results.The study follow-up was short, 12 weeks, and follow-up beyond
this time could have been of interest, especially after the observed
decline in function between 6 and 12 weeks. We must remark that
our population was very old and very frail, with chronic diseases, and
different rates of disability, so we could expect a naturalistic decline
in function at 12 weeks without intervention. Recently, Slaughter
et al42 found a 5.9% decrease in physical function measured with the
functional independence measure instrument at 6 months in an ur-
ban cohort of nursing home older adults with dementia, independent
for transferring (mean age 86.1, SD 7.1). Our population had higher
outcome scores at 12 weeks than baseline, making feasible a global
improvement compared with a nonintervention population of similar
characteristics.
The study was conducted in a country with well-developed health
and care services for older adults, the clinical teams involved had
considerable experience in nursing home health care, physiothera-
pists were involved in the exercise plan, and adherence was strictly
monitored. However, it should be of interest to generalize the inter-
vention to other situations with different health and care services.
Conclusions
A 12-week intervention with ONS plus physical exercise improves
function, nutritional status, and quality of life in frail institutionalized
older adults. This improvement is higher in participants with more
frailty criteria, lower functional level, lower vitamin D levels, and
with poorer nutritional status.
More than 90% of residents accomplished daily exercises, and
more than 80% accomplished with an oral intake of more than 60% of
ONS.
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